Skip to main content
Amgen8-K: Digital transformation

Amgen raises nearly $4 billion in capital from senior notes offering

What happened

Amgen secured approximately $3.96 billion in net proceeds from a debt offering, providing a massive capital reserve for significant strategic initiatives. This level of funding often precedes major investments in R&D, manufacturing expansion, or acquisitions, all of which require substantial technology and infrastructure support.

Source

SEC EDGARFeb 19, 2026

Current report (Form 8-K)

Amgen 8-K

Filing excerpt

On February 17, 2026, Amgen Inc. (the “Company”) issued and sold $1,000,000,000 aggregate principal amount of the Company’s 4.200% Senior Notes due 2031 (the “2031 Notes”), $1,750,000,000 aggregate principal amount of the Company’s 4.850% Senior Notes due 2036 (the “2036 Notes”), $500,000,000 aggregate principal amount of the Company’s 5.500% Senior Notes due 2046 (the “2046 Notes”) and $750,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes”...

sec.gov/Archives/edgar/data/318154/000119312526059490/d106293d8k.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Digital transformation

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Feb 19, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$4B (Net proceeds from senior notes offering for future strategic initiatives)

Details

CIK
318154
Accession number
0001193125-26-059490
Timeframe
Immediate
Filing year
2026
Why it matters
Multi-year tech investment
Signal category
Strategic

Topics and mentions

Vendors

  • BofA Securities
  • Inc.
  • Citigroup Global Markets Inc.
  • J.P. Morgan Securities LLC
  • Morgan Stanley & Co. LLC
  • The Bank of New York Mellon Trust Company
  • N.A.
  • Latham & Watkins LLP

Vendors named

  • BofA Securities, Inc.
  • Citigroup Global Markets Inc.
  • J.P. Morgan Securities LLC
  • Morgan Stanley & Co. LLC
  • The Bank of New York Mellon Trust Company, N.A.
  • Latham & Watkins LLP

Extraction

Confidence
Medium
Relevance
80%
Sentiment
Positive
Detected
Feb 24, 2026
signal_type
sec-8k
signal_subtype
digitalTransformation

Use this data

Get every 8-K signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/5a635ae0-556d-4cae-aa7f-b36b4c10502a returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "5a635ae0-556d-4cae-aa7f-b36b4c10502a",
  "signal_type": "sec-8k",
  "signal_subtype": "digitalTransformation",
  "detected_at": "2026-02-24T08:23:26.895+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "Amgen secured approximately $3.96 billion in net proceeds from a debt offering, providing a massive capital reserve for significant strategic initiatives. This level of funding often precedes major investments in R&D, manufacturing expansion, or acquisitions, all of which require substantial technology and infrastructure support.",
    "metrics": {
      "timeframe": "immediate",
      "dollar_context": "Net proceeds from senior notes offering for future strategic initiatives",
      "dollar_millions": 3961.5
    },
    "summary": "Amgen raises nearly $4 billion in capital from senior notes offering",
    "excerpts": "On February 17, 2026, Amgen Inc. (the “Company”) issued and sold $1,000,000,000 aggregate principal amount of the Company’s 4.200% Senior Notes due 2031 (the “2031 Notes”), $1,750,000,000 aggregate principal amount of the Company’s 4.850% Senior Notes due 2036 (the “2036 Notes”), $500,000,000 aggregate principal amount of the Company’s 5.500% Senior Notes due 2046 (the “2046 Notes”) and $750,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes”...",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "medium",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000119312526059490/d106293d8k.htm",
    "filing_date": "2026-02-19",
    "filing_year": 2026,
    "sales_relevance": "Multi-year tech investment",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "BofA Securities, Inc.",
      "Citigroup Global Markets Inc.",
      "J.P. Morgan Securities LLC",
      "Morgan Stanley & Co. LLC",
      "The Bank of New York Mellon Trust Company, N.A.",
      "Latham & Watkins LLP"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.